In main results from the phase 3 trial, as well as those from an open-label extension, the investigational drug also proved its ability to positively influence several noninvasive efficacy outcomes.
AstraZeneca (AZN) Reports Data for IMFINZI Combinations in Patients With Liver and Biliary Tract Cancers streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
VBI Vaccines (VBIV) Reports New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Presentation title: "Long-Term Persistence of Anti-HBs Antibodies after Vaccination with a 3-Antigen HBV Vaccine Compared with a Single-Antigen HBV Vaccine" VBI Vaccines Inc. (Nasdaq: VBIV) (VBI)